These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5001309)

  • 21. Social behavior of rhesus monkeys chronically exposed to moderate amounts of delta-9-tetrahydrocannabinol.
    Chapman LF; Sassenrath EN; Goo GP
    Adv Biosci; 1978 Jul 22-23; 22-23():693-712. PubMed ID: 116882
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and biological activity of five tetrahydrocannabinol metabolites.
    Mechoulam R; Varconi H; Ben-Zvi Z; Edery H; Grunfeld Y
    J Am Chem Soc; 1972 Nov; 94(22):7930-1. PubMed ID: 4627740
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of (-)- 9 - and (-)- 8 -tetrahydrocannabinol by monkey liver.
    Gurny O; Maynard DE; Pitcher RG; Kierstead RW
    J Am Chem Soc; 1972 Nov; 94(22):7928-9. PubMed ID: 4627739
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of delta-9-tetrahydrocannabinol on temporal and auditory discrimination performances of monkeys.
    Elsmore TF
    Psychopharmacologia; 1972; 26(1):62-72. PubMed ID: 4626286
    [No Abstract]   [Full Text] [Related]  

  • 26. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol.
    Dewey WL; McMillan DE; Harris LS; Turk RF
    Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys.
    Harris RT; Waters W; McLendon D
    Psychopharmacologia; 1974 Jun; 37(1):23-9. PubMed ID: 4413316
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification through synthesis of an active delta-1(6)-tetrahydrocannabinol metabolite.
    Ben-Zvi Z; Mechoulam R; Burstein S
    J Am Chem Soc; 1970 Jun; 92(11):3468-9. PubMed ID: 4987240
    [No Abstract]   [Full Text] [Related]  

  • 30. Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.
    Widman M; Nordqvist M; Agurell S; Lindgren JE; Sandberg F
    Biochem Pharmacol; 1974 Apr; 23(7):1163-72. PubMed ID: 4823449
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of marihuana (delta-9-tetrahydrocannabinol) on the secretion of luteinizing hormone in the ovariectomized rhesus monkey.
    Besch NF; Smith CG; Besch PK; Kaufman RH
    Am J Obstet Gynecol; 1977 Jul; 128(6):635-42. PubMed ID: 406789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta9-tetrahydrocannabinol-uptake by rat liver lysosomes.
    Irvin JE; Mellors A
    Biochem Pharmacol; 1975 Jan; 24(2):305-7. PubMed ID: 1111544
    [No Abstract]   [Full Text] [Related]  

  • 33. Transformation of delta-1-tetrahydrocannabinol (THC) by rabbit liver microsomes.
    Ben-Zvi Z; Burstein S
    Biochem Pharmacol; 1975 May; 24(10):1130-1. PubMed ID: 1156437
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.
    Radwan MM; ElSohly MA; El-Alfy AT; Ahmed SA; Slade D; Husni AS; Manly SP; Wilson L; Seale S; Cutler SJ; Ross SA
    J Nat Prod; 2015 Jun; 78(6):1271-6. PubMed ID: 26000707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
    Gill EW; Jones G
    Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
    [No Abstract]   [Full Text] [Related]  

  • 36. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations.
    Franz T; Skopp G; Schwarz G; Musshoff F
    Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in LC-MS/MS analysis of Δ(9)-tetrahydrocannabinol and its metabolites in biological matrices.
    Ferreirós N
    Bioanalysis; 2013 Nov; 5(21):2713-31. PubMed ID: 24180509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain levels and relative potency of the 1,2-dimethylheptyl analogue of delta1-tetrahydrocannabinol in mice.
    Lawrence DK; Pertwee RG; Gill EW; Piper JM
    Biochem Pharmacol; 1974 Nov; 23(21):3017-27. PubMed ID: 4429599
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Metabolism of delta 1-tetrahydrocannabinol by mouse hepatic microsomes: identification of 6alpha-hydroxytetrahydrocannabinol.
    Ben-Zvi Z; Burstein S; Zikopoulos J
    J Pharm Sci; 1974 Jul; 63(7):1173-4. PubMed ID: 4852855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.